Weekly shot may replace daily needle for kids with growth hormone deficiency

NCT ID NCT04970654

Completed Disease control Sponsor: Novo Nordisk A/S Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new medicine, somapacitan, given once a week against the standard daily growth hormone shot (Norditropin®) in 110 Chinese children with growth hormone deficiency. The goal was to see if the weekly shot works as well as the daily one for helping children grow. Children were randomly assigned to one treatment for 52 weeks, and researchers measured their growth rate and bone development.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

isolated congenital growth hormone deficiency

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GROWTH HORMONE DEFICIENCY IN CHILDREN

Contacts and locations

Locations

Beijing Children's Hospital, Capital Medical University

Beijing, Beijing Municipality, 100045, China
Capital Center for Children's Health, Capital Medical University-Endocrinology

Beijing, Beijing Municipality, 100020, China
Chengdu Women's and Children's Central Hospital

Chengdu, Sichuan, 610000, China
Children's Hospital of Soochow University

Suzhou, Jiangsu, 215025, China
Children's Hospital of Soochow University-Endocrine Genetics and Metabolism

Suzhou, Jiangsu, 215025, China
Children's Hospital, Zhejiang University School of Medicine

Hangzhou, Zhejiang, 310052, China
Henan Children's Hospital

Zhengzhou, Henan, 450018, China
Henan Children's Hospital Zhengzhou Children's Hospital-Endocrine Genetics and Metabolism

Zhengzhou, Henan, 450018, China
Hunan Children's Hospital

Changsha, Hunan, 410007, China
Hunan Children's Hospital-Child Health Center

Changsha, Hunan, 410007, China
Jiangxi Provincial Children's Hospital-Endocrine Genetics and Metabolism

Nanchang, Jiangsu, 330006, China
Pingxiang Maternal and Child Health Care Hospital

Pingxiang, Jiangxi, 337055, China
Pingxiang Maternal and Child Health Care Hospital-Child Health Care

Pingxiang, Jiangxi, 337055, China
Qingdao Women and Children's Hospital

Qingdao, Shandong, 266043, China
Qingdao Women and Children's Hospital-Pediatric Endocrinology&Metabolism

Qingdao, Shandong, 266034, China
Shandong Provincial Hospital-Pediatric

Jinan, Shandong, 250098, China
Shanghai Children's Hospital

Shanghai, Shanghai Municipality, 200062, China
The First Affiliated Hospital of Shaoyang University-Pediatric

Shaoyang, Hunan, 422001, China
The First Affiliated Hospital of Xiamen University-Pediatric

Xiamen, Fujian, 361003, China
The First Affiliated Hospital, Sun Yat-sen University

Guangzhou, Guangdong, 510080, China
The First Bethune Hospital of Jilin University-Pediatric

Changchun, Jilin, 130021, China
The First Bethune hospital of Jilin University-Endocrinology

Changchun, Julin, China
The First Hospital of Jiaxing

Jiaxing, Jiangxi, 314001, China
The First Hospital of Jiaxing-Pediatric

Jiaxing, Jiangxi, 314001, China
The Second Hospital of Anhui Medical University

Hefei, Anhui, 230601, China
The Second Xiangya Hospital of Central South University

Changsha, Hunan, 410011, China
The Third Affiliated Hospital, Sun Yat-Sen University-Pediatric

Guangzhou, Guangdong, 510630, China
Tongji Hospital, Tongji Medical College of HUST-Pediatric

Wuhan, Hubei, 430030, China
Women & Children's Health Care Hospital of Linyi-Endocrine Genetics and Metabolism

Linyi, Shandong, 276016, China
Wuhan Children Hospital-Endocrine Genetics and Metabolism

Wuhan, China
Wuxi Children's Hospital

Wuxi, Jiangsu, 214023, China
Wuxi Children's Hospital-Pediatric Endocrinology

Wuxi, Jiangsu, 214023, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.